Deuterated metabolic water precursor for detecting and treating diseased tissue
US10646594B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2010 |
| Grant date | May 12, 2020 |
| Priority date | — |
| Expiry date | Mar 13, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K49/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of diagnosing a mitochondrial related disease in a subject includes administering a deuterated metabolic water precursor to the subject, measuring a rate of deuterated water formation in a sample region of the subject, and comparing the measured deuterated water formation in the sample region to a control value. A difference between the rate of deuterated water formation in the sample region compared to a control value is indicative of a mitochondrial related disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.